Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast Cancer.

Details

Language :

English

ISSN :

00222623

Volume :

66

Issue :

20

Database :

Supplemental Index

Journal :

Journal of Medicinal Chemistry

Publication Type :

Academic Journal

Accession number :

173311387

Full Text :

https://doi.org/10.1021/acs.jmedchem.3c01242